Legge F - Search Results

1

Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.

Ferrandina G, Legge F, Ranelletti FO, Zannoni GF, Maggiano N, Evangelisti A, Mancuso S, Scambia G, Lauriola L. Ferrandina G, et al. Among authors: legge f. Cancer. 2002 Aug 15;95(4):801-7. doi: 10.1002/cncr.10736. Cancer. 2002. PMID: 12209724 Free article.

2

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy.

Comes MC, Arezzo F, Cormio G, Bove S, Calabrese A, Fanizzi A, Kardhashi A, La Forgia D, Legge F, Romagno I, Loizzi V, Massafra R. Comes MC, et al. Among authors: legge f. Front Oncol. 2023 Jul 13;13:1181792. doi: 10.3389/fonc.2023.1181792. eCollection 2023. Front Oncol. 2023. PMID: 37519818 Free PMC article.

3

Risk factors for ovarian cancer in central Italy.

Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C. Greggi S, et al. Among authors: legge f. Gynecol Oncol. 2000 Oct;79(1):50-4. doi: 10.1006/gyno.2000.5909. Gynecol Oncol. 2000. PMID: 11006030

4

[Familial ovarian carcinoma].

Greggi S, Legge F, Mancuso S. Greggi S, et al. Among authors: legge f. Minerva Ginecol. 2001 Feb;53(1 Suppl 1):3-5. Minerva Ginecol. 2001. PMID: 11526715 Italian. No abstract available.

5

[Biological factors with prognostic significance in ovarian cancer].

Ferrandina G, Legge F, Fagotti A, Fanfani F, Mancuso S, Scambia G. Ferrandina G, et al. Among authors: legge f. Minerva Ginecol. 2001 Feb;53(1 Suppl 1):40-5. Minerva Ginecol. 2001. PMID: 11526718 Review. Italian. No abstract available.

6

Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.

Ferrandina G, Ranelletti FO, Larocca LM, Maggiano N, Fruscella E, Legge F, Santeusanio G, Bombonati A, Mancuso S, Scambia G. Ferrandina G, et al. Among authors: legge f. Clin Cancer Res. 2001 Sep;7(9):2656-61. Clin Cancer Res. 2001. PMID: 11555576 Clinical Trial.

7

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

Ferrandina G, Lauriola L, Distefano MG, Zannoni GF, Gessi M, Legge F, Maggiano N, Mancuso S, Capelli A, Scambia G, Ranelletti FO. Ferrandina G, et al. Among authors: legge f. J Clin Oncol. 2002 Feb 15;20(4):973-81. doi: 10.1200/JCO.2002.20.4.973. J Clin Oncol. 2002. PMID: 11844819

8

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.

Ferrandina G, Ranelletti FO, Lauriola L, Fanfani F, Legge F, Mottolese M, Nicotra MR, Natali PG, Zakut VH, Scambia G. Ferrandina G, et al. Among authors: legge f. Gynecol Oncol. 2002 May;85(2):305-10. doi: 10.1006/gyno.2002.6620. Gynecol Oncol. 2002. PMID: 11972392

9

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

Ferrandina G, Lauriola L, Zannoni GF, Fagotti A, Fanfani F, Legge F, Maggiano N, Gessi M, Mancuso S, Ranelletti FO, Scambia G. Ferrandina G, et al. Among authors: legge f. Ann Oncol. 2002 Aug;13(8):1205-11. doi: 10.1093/annonc/mdf207. Ann Oncol. 2002. PMID: 12181243 Free article.

10

BRCA1-related malignancies in a family presenting with von Recklinghausen's disease.

Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D'Amico F, Greggi S, Scambia G. Ceccaroni M, et al. Among authors: legge f. Gynecol Oncol. 2002 Sep;86(3):375-8. doi: 10.1006/gyno.2002.6757. Gynecol Oncol. 2002. PMID: 12217765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters